Management of Native Lung Malignancy in a Lung Transplant Recipient

Innovations (Phila). 2022 Nov-Dec;17(6):567-569. doi: 10.1177/15569845221133119. Epub 2022 Nov 17.

Abstract

A 75-year-old male patient with a history of previous right lung transplant presented with left upper lobe squamous cell carcinoma. Endobronchial ultrasound and positron emission tomography displayed no mediastinal lymphadenopathy. A ventilation-perfusion scan displayed minimal perfusion to the native lung. Left robot-assisted lysis of adhesions, decortication, left upper lobectomy, and mediastinal lymphadenectomy were performed. The patient tolerated the procedure well. Final pathology displayed pT2a, n0, m0. Lobectomy is a safe and efficient treatment of native lung malignancy in the setting of previous lung transplant with minimally functioning native lung.

Keywords: lobectomy; lung cancer; lung squamous cell carcinoma; lung transplant; robotic surgery.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Carcinoma, Squamous Cell* / pathology
  • Carcinoma, Squamous Cell* / surgery
  • Humans
  • Lung / pathology
  • Lung Neoplasms* / pathology
  • Lung Neoplasms* / surgery
  • Lung Transplantation*
  • Male
  • Transplant Recipients